539 Results

People

  1. Eastham
    Eastham
  2. Vickers
    Vickers
  3. Scardino
    Scardino
  4. Reuter
    Reuter
  5. Zelefsky
    Zelefsky
  6. Hricak
    Hricak
  7. Kattan
    Kattan
  8. Fine
    Fine
  9. Fair
    Fair
  10. Lilja
    Lilja

Groups

  1. Surgery (205)
  2. Urology (199)
  3. Sloan Kettering Institute Faculty (142)
  4. Molecular Pharmacology and Chemistry Program Faculty (136)
  5. Population Sciences Research Program (105)
  6. Medical Physics (95)
  7. Epidemiology and Biostatistics (89)
  8. GSK Faculty (80)
  9. Department of Pathology and Laboratory Medicine (77)
  10. Health Outcomes Research Group (69)
  1. "prostate"
Formats
  1. Journal Article (471)
  2. Review (20)
  3. Conference Paper (11)
  4. Editorial (11)
  5. Book Section (8)
  6. Correspondence (6)
  7. Guidelines (6)
  8. Meeting Abstract (6)
Groups
  1. Surgery (205)
  2. Urology (199)
  3. Sloan Kettering Institute Faculty (142)
  4. Molecular Pharmacology and Chemistry Program Faculty (136)
  5. Population Sciences Research Program (105)
  6. Medical Physics (95)

More Groups

People
  1. Peter Scardino (92)
  2. James Eastham (73)
  3. Andrew Vickers (50)
  4. Victor Reuter (43)
  5. Michael Zelefsky (41)
  6. Hedvig Hricak (35)

More People

Years
  1. 2025 (6)
  2. 2024 (28)
  3. 2023 (41)
  4. 2022 (33)
  5. 2021 (8)
  6. 2020 (6)

More Years

Publications
  1. Journal of Urology (100)
  2. International Journal of Radiation Oncology, Biology, Physics (31)
  3. BJU International (26)
  4. European Urology (26)
  5. Prostate (16)
  6. Urology (14)

More Publications

Publishers
  1. Elsevier Science, Inc. (162)
  2. Elsevier Inc. (87)
  3. Wiley Blackwell (57)
  4. John Wiley & Sons (26)
  5. American Association for Cancer Research (20)
  6. Lippincott Williams & Wilkins (18)

More Publishers

Results (539)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: A multi-institutional pooled analysis
    Journal Article

    Horwitz, E. M.; Thames, H. D.; Kuban, D. A.; Levy, L. B.; Kupelian, P. A.; Martinez, A. A.; Michalski, J. M.; Pisansky, T. M.; Sandler, H. M.; Shipley, W. U.; more...
    Journal of Urology (2005)

    Fulltext@MSK | Save
  • Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and gleason grade
    Journal Article

    Haese, A.; Vaisanen, V.; Lilja, H.; Kattan, M. W.; Rittenhouse, H. G.; Pettersson, K.; Chan, D. W.; Huland, H.; Sokoll, L. J.; Partin, A. W.
    Journal of Urology (2005)

    Fulltext@MSK | Save
  • Prostate-specific antigen doubling time as a prognostic marker in prostate cancer
    Journal Article

    Eastham, J. A.
    Nature Clinical Practice Urology (2005)

    Fulltext@MSK | Save
  • Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk
    Journal Article

    Crook, J. M.; Potters, L.; Stock, R. G.; Zelefsky, M. J.
    Brachytherapy (2005)

    Fulltext@MSK | Save
  • Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
    Journal Article

    Chen, Z.; Trotman, L. C.; Shaffer, D.; Lin, H. K.; Dotan, Z. A.; Niki, M.; Koutcher, J. A.; Scher, H. I.; Ludwig, T.; Gerald, W.; more...
    Nature (2005)

    Fulltext@MSK | Save
  • Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy
    Journal Article

    Carver, B. S.; Kattan, M. W.; Scardino, P. T.; Eastham, J. A.
    BJU International (2005)

    Fulltext@MSK | Save
  • Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Journal Article

    Boorjian, S. A.; Bianco, F. J. Jr; Scardino, P. T.; Eastham, J. A.
    BJU International (2005)

    Fulltext@MSK | Save
  • The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
    Journal Article

    Zackrisson, B.; Aus, G.; Bergdahl, S.; Lilja, H.; Lodding, P.; Pihl, C. G.; Hugosson, J.
    Journal of Urology (2004)

    Fulltext@MSK | Save
  • Mucinous adenocarcinoma of the prostate: A case report of long-term disease-free survival and a review of the literature
    Journal Article

    Rhee, A. C.; Olgac, S.; Ohori, M.; Russo, P.
    Urology (2004)

    Fulltext@MSK | Save
  • An analysis of men with clinically localized prostate cancer who deferred definitive therapy
    Journal Article

    Patel, M. I.; Deconcini, D. T.; Lopez-Corona, E.; Ohori, M.; Wheeler, T.; Scardino, P. T.
    Journal of Urology (2004)

    Fulltext@MSK | Save